Fatty acid metabolism-related lncRNAs are potential biomarkers for survival prediction in clear cell renal cell carcinoma

Ming-Qing Zhang,Bai-Zhi Yang,Zhi-Qiang Wang,Shanchun Guo

DOI: https://doi.org/10.1097/md.0000000000037207

IF: 1.6

2024-02-25

Medicine

Abstract:Renal cell carcinoma (RCC) is a prevalent malignant tumor of the urinary system that mostly arises from renal tubular epithelial cells. It constitutes around 2% to 3% of all adult malignancies. [ 1 ] The prevalence of RCC is rising by 2% annually in developed nations. [ 2 ] The clear cell renal cell carcinoma (ccRCC) is a prevalent histopathologic subtype, making up 80% to 90% of all RCC. [ 3 ] Approximately 30% of patients with ccRCC were already in an advanced stage due to the absence of distinctive clinical signs. [ 4–7 ] Approximately 40% of patients continue to encounter disease recurrence, primarily within the initial 5 years following surgery. Furthermore, patients with ccRCC exhibit notably inferior 5-year recurrence-free survival (RFS) rates in comparison to patients with other forms of renal cell carcinoma (RCC). [ 8 ] ccRCC exhibits a highly aggressive biological behavior, resulting in a dismal prognosis [ 9 ] {Kim, 2021 #99}. Hence, there is a pressing requirement for novel clinical indicators for ccRCC patients.

medicine, general & internal